CCCC (c4therapeutics.com) מקדם שווי פעילות להכנסות

סמלים רשמיים של חברת C4 Therapeutics Inc (CCCC)

C4 Therapeutics, Inc. (CCCC) develops innovative oncology drugs leveraging a proprietary protein degradation system for long-term sustainability. The EV/Sales multiple helps assess the business value relative to revenue, with 5274.47 representing the current value of this metric. Successes with the drug CFT7455 and partnerships with industry behemoths are driving share growth. High confidence among scientists confirms the fundamental strength of the company's scientific foundation.

c4therapeutics.com (CCCC): מכפיל EV/Sales מ-23.11.2025 עד 20.11.2026

פילוחי מדדים פיננסיים ומדדי שוק עבור C4 Therapeutics (CCCC)

- מחיר ותחזית קונצנזוס למחירים:
- מדדי הערכת שווי שוק של העסק:
הערכת שווי פונדמנטלית של החברה:C4 Therapeutics, Inc. CCCC
דוגמת מוצר של c4therapeutics.com

C4 Therapeutics, Inc. (CCCC) maintains minimal internal capex due to the outsourcing of production and testing to third-party contractors. The EV/Sales metric relates the total enterprise value, including debt, to sales volume, thereby eliminating the impact of financial leverage. This allows for an assessment of the market value of every dollar of revenue without distortions from the capital structure. Investors decouple fundamental value from volatility by analyzing changes in EV/Sales. The trend of this indicator reveals asset overvaluation relative to actual operational scale.